JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Together, these findings provide strong evidence that AHI-1-BCR-ABL-JAK2 complex modulates response/resistance to TKIs in CML stem/progenitor cells (Figure 5D).